Clinical Trial

Aveir AR Coverage With Evidence Development (CED) Study

Study acronym: ARRIVE
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Atrial Leadless Pacemaker device (aka Aveir™ AR LP system).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-20; most recent amendment 2025-04-02.
Status change: Not Yet Recruiting → Recruiting 2024-01-19
Trial Details
NCT Number NCT06100770
Lead Sponsor Abbott Medical Devices
Conditions Cardiac Pacemaker, Arrhythmia, Bradycardia
Enrollment 586 participants
Start Date 2024-01-18
Primary Completion 2030-01 (estimated)
Study Completion 2031-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-04